Atezolizumab doubles survival of NSCLC patients with poor performance statusSeptember 19, 2022Lung Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
‘Smoking gun–level’ evidence found linking air pollution with lung cancerSeptember 14, 2022Lung CancerMelanoma
Nearly 30% of U.S. cancer deaths linked to smokingAugust 30, 2022Lung CancerPreventive CareHead & Neck/Thyroid Cancers
Lung adverse effects in patients taking trastuzumab deruxtecanAugust 18, 2022Lung CancerPatient & Survivor CareBreast CancerGastrointestinal Cancer
The ‘great dynamism’ of radiation oncologyAugust 18, 2022Lung CancerMixed TopicsBreast CancerHead & Neck/Thyroid CancersGenitourinary Cancer
Getting cancer research on track again may require a ‘behemoth’ effortAugust 15, 2022Mixed TopicsBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
